Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision –
Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision Endpoints NewsBristol Myers Squibb Stock Falls After Delay to Gene Therapy Drug Approval Barron'sBristol Myers Squibb (NYSE:BMY) Falls after FDA Delays Action on…